MedTrace Logo

Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy

NCT02040155 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2017-05-05

No results posted yet for this study

Summary

This is an observational study. The purpose is to determine the feasibility of using a novel nano-scintillator fiber-optic dosimeter (nanoFOD) for the real time dosimetric monitoring of brachytherapy treatment. Women with gynecologic cancers treated with brachytherapy as part of their standard therapeutic regimen will represent the study population.

Conditions

  • Cancer of the Cervix, Cancer of the Endometrium

Interventions

DEVICE

Novel nano-scintillator fiber-optic dosimeter (nanoFOD)

This is an observational study whose purpose is to determine the feasibility of using a novel nano-scintillator fiber-optic dosimeter (nanoFOD) for the real time dosimetric monitoring of brachytherapy treatment.

Sponsors & Collaborators

  • Wallace H. Coulter Foundation

    collaborator OTHER

  • Duke University

    lead OTHER

Principal Investigators

  • Junzo Chino, MD · Duke Health

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02040155 on ClinicalTrials.gov